Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance. Emerging research reveals that the ...

Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established ...

Following multiple meetings with the FDA, ImmunityBio submitted additional information requested by the Agency to support its supplemental BLA (sBLA) for papillary ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a strategic expansion ...

Chen, M.Y. and Luo, L.P. (2026) CT and MRI Findings of Epithelioid Hemangioma of Bone: A Case Report. Journal of Biosciences and Medicines, 14, 246-252. doi: 10.4236/jbm.2026.143018 .

SISSA Colloquium returns on Wednesday, March 18th, at 2 PM in Aula Magna Budinich. This time, we will have the pleasure of hosting Professor Huib Mansvelder (Vrije Universiteit Amsterdam), who will ...